Redefining Ancient Orphism (A Study in Greek Religion) || Orphism through the ages
- 作者Edmonds III, Radcliffe G.
- 文件大小520.62KB
- 发表时间2013
- DOI10.1017/CBO9781139814669.003
- 页码11-70
Identification of cartilage oligomeric matrix protein as biomarker predicting abatacept response in rheumatoid arthritis patients with insufficient response to a first anti-TNFα treatmentNguyen, Minh Vu Chuong; Adrait, Annie; Baillet, Athan; Trocmé, Candice; Gottenberg, Jacques-Eric; Gaudin, Philippe · Joint Bone Spine · 2018
Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular CarcinomaCho, Jinhyun; Lee, Jeeyun; Kim, Jusun; Kim, Seung Tae; Lee, Sujin; Kim, Sun Young; Ha, Sang Yun; Park, Cheol-Keun; Lim, Ho Yeong · Translational Oncology · 2016
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesionsIppolito, Davide; Querques, Giulia; Okolicsanyi, Stefano; Talei Franzesi, Cammillo; Pecorelli, Anna; Lombardi, Sophie; Orsini, Eleonora; Strazzabosco, Mario; Sironi, Sandro · European Journal of Radiology · 2018
A Feasibility Study Evaluating the Functional Diffusion Map as a Predictive Imaging Biomarker for Detection of Treatment Response in a Patient with Metastatic Prostate Cancer to the BoneLee, Kuei C.; Bradley, Deborah A.; Hussain, Maha; Meyer, Charles R.; Chenevert, Thomas L.; Jacobson, Jon A.; Johnson, Timothy D.; Galban, Craig J.; Rehemtulla, Alnawaz; Pienta, Kenneth J.; Ross, Brian D. · Neoplasia · 2007
Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patientsZhu, Ming-Yu; Chen, Pei-Zhan; Li, Jing; Yu, De-Min; Huang, Dao; Zhu, Xue-Juan; Han, Yue; Chen, Jie; Huang, Wei; Chen, Yong-Yan; Gong, Qi-Ming; Jiang, Jie-Hong; Zhang, Dong-Hua; Zhang, Yan; Zhang, Ji-Ming; Zhang, Xin-Xin · Journal of Medical Virology · 2017
A roadmap to a cureStevenson, Mario · Retrovirology · 2012
Primary HIV infection: the French experienceGoujard, C�cile · Retrovirology · 2012
Treating since the beginning?Routy, Jean-Pierre · Retrovirology · 2012
HCV resistanceHalfon, Philippe · Retrovirology · 2012
What happens after hepatitis C eradication?Pol, Stanislas · Retrovirology · 2012
Clinical use of pharmacogenomicsTelenti, Amalio · Retrovirology · 2012
Antiretroviral genericsAndrieu, V�ronique · Retrovirology · 2012
Human papilloma virusesGalloway, Denise A · Retrovirology · 2012